首页> 外文期刊>Journal of Diabetes Science and Technology >Analysis of Use of an Automated Bolus Calculator Reduces Fear of Hypoglycemia and Improves Confidence in Dosage Accuracy in Type 1 Diabetes Mellitus Patients Treated with Multiple Daily Insulin Injections
【24h】

Analysis of Use of an Automated Bolus Calculator Reduces Fear of Hypoglycemia and Improves Confidence in Dosage Accuracy in Type 1 Diabetes Mellitus Patients Treated with Multiple Daily Insulin Injections

机译:使用自动量计算器的分析减少了每日多次注射胰岛素治疗的1型糖尿病患者对低血糖症的恐惧并提高了剂量准确性的可信度

获取原文
       

摘要

In this issue of Journal of Diabetes Science and Technology , Barnard and colleagues evaluate the use of the ACCU-CHEK? Aviva Expert blood glucose meter/bolus advisor system in patients with type 1 diabetes mellitus. Hypoglycemia is a major limiting factor to intensive glucose control, and fear of hypoglycemia, especially in those who have experienced severe reactions, is a major barrier. The bolus advisor improved overall glucose control and increased adherence by overcoming the patients' fear of hypoglycemia, giving them more confidence to give adequate doses of insulin to control hyperglycemia. In this review, we discuss other human factors that become barriers to intensive control, which can benefit from new technologies, including numeracy literacy, information overload, time required for diabetes self-care, and device incompatibility.
机译:在本期《糖尿病科学与技术杂志》中,Barnard及其同事评估了ACCU-CHEK的使用。 Aviva Expert血糖仪/推注顾问系统可用于1型糖尿病患者。低血糖症是严格控制血糖的主要限制因素,对低血糖症的恐惧(尤其是那些经历严重反应的人)是主要障碍。大剂量顾问克服了患者对低血糖症的恐惧,改善了整体血糖控制并增加了依从性,使他们更有信心给予足够剂量的胰岛素来控制高血糖症。在这篇综述中,我们讨论了其他人为因素,这些因素会成为强化控制的障碍,这些因素可以从新技术中受益,包括算术素养,信息超载,糖尿病自我护理所需的时间以及设备不兼容。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号